Universal Lifelong Fungal Prophylaxis and Risk of Coccidioidomycosis in Lung Transplant Recipients Living in an Endemic Area

Overview of attention for article published in Clinical Infectious Diseases, August 2021

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (64th percentile)

Mentioned by

twitter: 6 X users

Readers on

mendeley: 29 Mendeley

So far, Altmetric has seen 7 X posts from 6 X users, with an upper bound of 14,720 followers.

RT @TransplantIDNet: .@AST_IDCOP guidelines rec 6-12 mos #Coccidioides ppx in endemic areas. @CIDJournal study of lung txp in Arizona had…

.@AST_IDCOP guidelines rec 6-12 mos #Coccidioides ppx in endemic areas. @CIDJournal study of lung txp in Arizona had lifelong azole ppx. 1/500 case, off ppx. Thanks to @NicoBarrosID for adding this to "Endemic mycoses" folder at https://t.co/OMnPL7P1O…

Kudos! to our own Dr. Kellie Goodlet for publishing two research articles on opportunistic infections in lung transplant patients in Clinical Infectious Diseases and AJHP. Congrats, Dr. Goodlet!! #MWUproud https://t.co/Q1Ihlcdc77 https://t.co/N91Ly9Pxtr

Recommendations are for 6-12 months of antifungal prophylaxis to prevent coccidioidomycosis in SOT recipients living in endemic areas. For lung xplnat some do lifelong azole prophylaxis. This study showed such a strategy all but eliminated risk. https:/…

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 3 additional X posts.